| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -7.82K | 100% | $2.68 | -$20.9K |
| Net | -1 | -7.82K | -100% | -$20.9K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Bayer Healthcare Llc | 10%+ Owner | $11.7M | Feb 13, 2024 | ||
| Brian C. Thomas | Chief Executive Officer, Director | $7.19M | Apr 1, 2024 | ||
| Sebastian Bernales | Director | $6.62M | Apr 1, 2024 | ||
| Novo Holdings A/S | 10%+ Owner | $5.01M | Feb 9, 2024 | ||
| Jian Irish | Title: President and Chief Operating Officer, Director | $1.37M | Apr 1, 2024 | ||
| Simon Harnest | Title: Chief Investment Officer and Senior Vice President of Strategy | $353K | Apr 1, 2024 | ||
| Sarah B. Noonberg | Chief Medical Officer | $289K | Apr 1, 2024 | ||
| Simren Delaney | Title: Vice President of Intellectual Property and Legal Operations | $270K | Apr 1, 2024 | ||
| Luis Borges | Chief Scientific Officer | $200K | Apr 1, 2024 | ||
| Willard H. Dere | Director | $148K | Apr 1, 2024 | ||
| Pamela Wapnick | Chief Financial Officer | $114K | -$20.9K | -15.5% | Dec 5, 2024 |
| Matthew Wein | Title: Vice President of Corporate Legal and Compliance, and Corporate Secretary | $29.9K | Apr 1, 2024 | ||
| Juergen Eckhardt | Director | Apr 1, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|